Mari Yamamoto
Onomichi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.
Journal: Breast cancer research and treatment
Published: April 14, 2024
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.
Journal: Breast cancer (Tokyo, Japan)
Published: November 30, 2023
Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10.
Journal: Clinical breast cancer
Published: April 20, 2023
Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Journal: Scientific reports
Published: March 24, 2023
The Systemic Immune Markers at Diagnosis Can Predict the Survival Benefit in Advanced Breast Cancer.
The Systemic Immune Markers at Diagnosis Can Predict the Survival Benefit in Advanced Breast Cancer.
Journal: Cancer diagnosis & prognosis
Published: September 15, 2021
Prognostic Value of Lymphocyte-to-Monocyte Ratio for Japanese Patients With Differentiated Thyroid Cancer Treated With Sorafenib Therapy.
Journal: Cancer diagnosis & prognosis
Published: July 06, 2021
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Journal: Acta medica Okayama
Published: June 28, 2021
Systemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer.
Journal: Scientific reports
Published: October 24, 2020
Aortitis which developed after the administration of granulocyte-colony stimulating factor.
Journal: Modern rheumatology case reports
Published: October 22, 2020
De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast Cancer: A Retrospective Observational Study.
Journal: In vivo (Athens, Greece)
Published: September 25, 2020
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: February 23, 2018
Last Updated: 09/26/2026